Nuvectis Pharma GAAP EPS of -$0.30
Source: SeekingAlpha
2025-08-05 08:34:13 ET
More on Nuvectis Pharma
- Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In
- Seeking Alpha’s Quant Rating on Nuvectis Pharma
- Historical earnings data for Nuvectis Pharma
- Financial information for Nuvectis Pharma
Read the full article on Seeking Alpha
For further details see:
Nuvectis Pharma GAAP EPS of -$0.30
Nuvectis Pharma Inc.
NASDAQ: NVCT
NVCT Trading
-1.85% G/L:
$9.04 Last:
23,006 Volume:
$9.16 Open:
NVCT Latest News
February 11, 2026 07:30:00 am
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
NVCT Stock Data
$223,874,191
14,667,089
29.18%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Fort Lee
